Return to Listing

1 result(s) for

PI Name Protocol # Title
Prakash Ambady STUDY00021284 (Advarra-IRB) A Phase 3, Multicenter, Randomized, Double-blind, Placebo-Controlled Study of AG-881 in Subjects With Residual or Recurrent Grade 2 Glioma With an IDH1 or IDH2 Mutation

You may also qualify for Phase 1 Program trials.

For more information:
Call: 503-494-1080